Doctors have devised a way of building a new retinal pigment epithelium and surgically implanting it into the eye. The technique, published in Nature Biotechnology, starts with embryonic stem cells.
noninvasive corneal cross-linking drug therapy that does not require removal of the corneal epithelium, the outermost layer of the front of the eye,” Thomas Burns, chairman and CEO of Glaukos ...